XML 96 R77.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity Compensation (Summary of Outstanding Options Vesting, Expected to Vest, or Exercisable) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Mar. 30, 2024
Mar. 25, 2023
Mar. 26, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]      
Number of Options, Vested and expected to vest (in shares) 774    
Weighted Average Exercise Price, Vested and expected to vest (in dollars per share) $ 74.26    
Weighted Average Remaining Contractual Term, Vested and expected to vest 6 years 7 months 6 days    
Aggregate Intrinsic Value, Vested and expected to vest $ 15,226    
Number of Options, Exercisable (in shares) 494 500 600
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 63.84    
Weighted Average Remaining Contractual Term, Exercisable 5 years 3 months    
Aggregate Intrinsic Value, Exercisable $ 14,443